SpectronRx

Congratulations to @TelixPharma on dosing the first patient in the Phase III IPAX BrIGHT trial evaluating TLX101-Tx for recurrent glioblastoma. auntminnie.com/clinical-news/… #Radiopharmaceuticals #NuclearMedicine #Oncology #ClinicalTrials #Theranostics

Exciting news. Stanford researchers have developed a novel PET imaging tracer designed to detect the earliest signs of multiple sclerosis before symptoms appear: med.stanford.edu/radiology/news… #Radiopharmaceuticals #NuclearMedicine #PETImaging #MultipleSclerosis #Theranostics

We’re excited to welcome Joanna Suan as VP of Marketing & Strategy at SpectronRx. #Radiopharmaceuticals #NuclearMedicine #PrecisionMedicine #CDMO #IsotopeProduction #Biotech #Pharma #Theranostics

An insightful perspective in Pharmaphorum: As radiopharmaceutical development accelerates, preclinical strategy hasn’t kept pace, and the gap is becoming a real bottleneck. pharmaphorum.com/oncology/radio… #Radiopharmaceuticals #NuclearMedicine #CDMO

When you’re working with short-lived isotopes, precision isn’t just about science. It’s about logistics. Experience the SpectronRx difference: spectronrx.com #Radiopharmaceuticals #NuclearMedicine #CDMO #IsotopeProduction #Theranostics #Biotech #Pharma #SupplyChain

Join SpectronRx at SNMMI 2026 in sunny Southern California and see how we are redefining what is possible in radiopharmaceutical contract development and manufacturing. Visit us at Booth 1023. #Radiopharmaceuticals #NuclearMedicine #CDMO #IsotopeProduction #Theranostics #SNMMI

We’re scaling at the speed of innovation. In a market moving this fast, scale, speed, and reliability aren’t optional. They’re everything. Read more here: mddionline.com/business/-85m-… #Radiopharmaceuticals #NuclearMedicine #PrecisionMedicine #CDMO #IsotopeProduction #Theranostics

SpectronRx has secured $85 million in financing from OrbiMed to expand medical isotope production and CDMO/CMO capabilities at our Grissom Aeroplex campus. dotmed.com/news/story/662… #Radiopharmaceuticals #NuclearMedicine #PrecisionMedicine #CDMO #IsotopeProduction #Theranostics

In radiopharmaceuticals, downtime is not an option. That’s why at SpectronRx, redundancy is built into our operations. Experience the SpectronRx difference: spectronrx.com #Radiopharmaceuticals #NuclearMedicine #CDMO #IsotopeProduction #Biotech #Pharma #Theranostics

At SpectronRx, we’re actively hiring across multiple disciplines. Explore opportunities and apply here: #cmp-skip-header-desktop" target="_blank" rel="nofollow noopener">indeed.com/cmp/Spectronrx… #Radiopharmaceuticals #NuclearMedicine #Careers #Hiring #Biotech #Pharma #CDMO #IsotopeProduction #PrecisionMedicine

The radiopharmaceutical industry is evolving fast, but many teams still rely on fragmented vendor networks. At SpectronRx, we’ve built a fully integrated platform, bringing it all together under one roof. spectronrx.com #Radiopharma #NuclearMedicine #CDMO

At SpectronRx, we’ve built a fully integrated platform—combining isotope production, development, and GMP manufacturing under one roof. And we’re here to support your path to commercialization. spectronrx.com #Radiopharmaceuticals #NuclearMedicine #CDMO

The countdown to the SNMMI 2026 Annual Meeting is on, and the SpectronRx team will be heading to Los Angeles from May 30 to June 2 for all the excitement. 📩 Message us to schedule a meeting. #SNMMI2026 #Radiopharma #IsotopeSupply #CDMO #NuclearMedicine #Radiopharmaceuticals

Can you access the isotopes you need at the scale, quality, and reliability your program demands? If the answer is no, we've got you covered! Experience the SpectronRx difference today: spectronrx.com #Radiopharmaceuticals #IsotopeProduction #NuclearMedicine #CDMO

New research suggests PSMA PET/CT imaging could cut prostate biopsies in half after inconclusive MRI scans. A powerful example of how radiopharmaceutical imaging is advancing precision medicine. eurekalert.org/news-releases/… #NuclearMedicine #Radiopharmaceuticals

A new market research report projects that the global radiopharmaceutical CDMO/CMO services market could exceed $7 billion by 2035, growing at an estimated 9.2% CAGR over the next decade. openpr.com/news/4420609/r… #Radiopharmaceuticals #NuclearMedicine #CDMO #IsotopeProduction

At SpectronRx, we have built the capabilities needed to support the next generation of diagnostic and therapeutic radiopharmaceuticals, from isotope production to contract development and manufacturing. 👉SpectronRx.com #Radiopharmaceuticals #NuclearMedicine #CDMO

See how SpectronRx is helping power the future of nuclear medicine: youtube.com/watch?v=EYGr0z… #Radiopharmaceuticals #NuclearMedicine #PrecisionMedicine #Indiana #LifeSciences #AdvancedManufacturing #SpectronRx

In case you missed it earlier this week, @IIB featured how SpectronRx is expanding isotope production to help meet the rapidly growing demand for radiopharmaceuticals. Watch the full segment here: youtube.com/watch?v=EYGr0z… #Radiopharmaceuticals #NuclearMedicine #PrecisionMedicine

Radioisotopes have to be created, and @SpectronRx is doing just that at a rapidly growing pace at its recently expanded campus near Grissom Air Reserve Base in Bunker Hill. The company will soon have 12 cyclotrons. insideindianabusiness.com/articles/spect…